Ligand Pharmaceuticals Inc
F:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
F:LGDN
|
US |
Wall St Price Targets
LGDN Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for LGDN is 181.18 EUR with a low forecast of 135.35 EUR and a high forecast of 221.03 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LGDN's stock price target?
Price Target
181.18
EUR
According to Wall Street analysts, the average 1-year price target for LGDN is 181.18 EUR with a low forecast of 135.35 EUR and a high forecast of 221.03 EUR.
What is the Revenue forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 8 years is 19%.
What is the Gross Profit forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 7 years is 21%.
What is the Pre-Tax Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
25%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 25%.
What is the Net Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Net Income over the next 7 years is 26%.
